Showing results (841-850 of 1,519) with videos related to
Sort By:
Pageof 152
Development (Cambridge, England)|October 1, 1992
Sequence and embryonic expression of the murine Hox-3.5 geneA M Geada, S J Gaunt, M Azzawi, et al.European Journal of Applied Physiology|April 30, 2017
Adaptations in corticospinal excitability and inhibition are not spatially confined to the agonist muscle following strength trainingJoel Mason, Ashlyn Frazer, Deanna M Horvath, et al.Journal of Science and Medicine in Sport|November 28, 2018
Female rugby union injuries in New Zealand: A review of five years (2013-2017) of Accident Compensation Corporation moderate to severe claims and costsD King, P A Hume, N Hardaker, et al.The Canadian Journal of Cardiology|April 3, 2009
The effect of place of residence on access to invasive cardiac services following acute myocardial infarctionAnsar Hassan, Neil J Pearce, Jim Mathers, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Cutting edge: Helminth infection induces IgE in the absence of mu- or delta-chain expressionGeorgia Perona-Wright, Katja Mohrs, Justin Taylor, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2007
Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivoGabriele Schramm, Katja Mohrs, Maren Wodrich, et al.Optics Express|June 12, 2009
Bend loss in all-solid bandgap fibresT A Birks, F Luan, G J Pearce, et al.Journal of Science and Medicine in Sport|June 24, 2009
Hip adductor muscle strength is reduced preceding and during the onset of groin pain in elite junior Australian football playersJustin F Crow, Alan J Pearce, James P Veale, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1986
Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccineE J Pearce, S L James, J Dalton, et al.Archives of Dermatology|August 23, 2006
Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasisDaniel J Pearce, Stephen Klinger, Kristin K Ziel, et al.Pageof 152